Major ABO mismatching is not considered a contraindication to allogeneic haematopoietic
stem cell transplantation ( HSCT ). Modern reduced‐intensity conditioning and reduced‐…

Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in patients
receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments are …

Objectives: To differentiate the leprosy agents Mycobacterium leprae and Mycobacterium
lepromatosis and correlate them with geographic distribution and clinicopathologic features. …

PURPOSE BK virus-associated hemorrhagic cystitis (BKV-HC) is a common complication of
allogenic hematopoietic stem cell transplantation (AHSCT), particularly in recipients of …

Background COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if
given at an early stage of the disease. Our study aimed to identify an association between …

Background Ovarian cancer patients have a high risk of developing venous thrombosis. The
membrane lipid bilayer of platelets and platelet-derived microparticles (PMP) provides a …

Background The use of centrifugation-based approaches for processing donated blood into
components is routine in the industrialized world, as disparate storage conditions require the …

Cyclooxygenase (COX) is the rate-limiting enzyme in conversion of arachidonic acid to
prostanoids, and has two isoforms, COX1 and COX2, which share ~65% amino acid homology. …

In major ABO-mismatched allogeneic hematopoietic stem cell transplantation (HSCT)
persistence of antidonor isohemagglutinins leads to pure red cell aplasia (PRCA). To investigate …

Patients with hematological malignancies often have severe thrombocytopenia, which poses
problems when making thrombosis management decisions. A retrospective study was …